UnitedHealth Group Incorporated (UNH) Financial Statements
UnitedHealth Group Incorporated (UNH) reported trailing twelve-month revenue of $450.1B (up 6.5% year on year) and net income of $14.1B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $23.6B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 375.3B
- P/E TTM
- 26.9
- Dividend yield
- 2.1%
- 52-week
- —
- Next earnings
- 25 Jan, in 93 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26. Results for the next quarter were released 13 Oct; these figures move once the 10-Q is filed.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 87.14 | 94.16 | 101.86 | 110.62 | 122.49 | 130.47 | 157.11 | 184.84 | 201.16 | 226.25 | 242.16 | 257.14 | 287.60 | 324.16 | 371.62 | 400.28 | 447.57 | 450.13 | |
| Gross profit | 85.37 | 92.04 | 99.48 | 108.10 | 119.60 | 126.65 | 140.90 | 160.42 | 177.05 | 199.25 | 214.04 | 226.40 | 256.56 | 290.46 | 332.85 | 353.58 | 396.91 | 398.69 | |
| Operating income | 6.36 | 7.86 | 8.46 | 9.25 | 9.62 | 10.27 | 11.02 | 12.93 | 15.21 | 17.34 | 19.69 | 22.41 | 23.97 | 28.44 | 32.36 | 32.29 | 18.96 | 21.68 | |
| Pre-tax income | 5.81 | 7.38 | 7.96 | 8.62 | 8.92 | 9.66 | 10.23 | 11.86 | 14.02 | 15.94 | 17.98 | 20.74 | 22.31 | 26.34 | 29.11 | 20.07 | 14.70 | 17.44 | |
| Income tax | 1.99 | 2.75 | 2.82 | 3.10 | 3.24 | 4.04 | 4.36 | 4.79 | 3.20 | 3.56 | 3.74 | 4.97 | 4.58 | 5.70 | 5.97 | 4.83 | 1.89 | 2.53 | |
| Net income | 3.82 | 4.63 | 5.14 | 5.53 | 5.63 | 5.62 | 5.81 | 7.02 | 10.56 | 11.99 | 13.84 | 15.40 | 17.29 | 20.12 | 22.38 | 14.41 | 12.06 | 14.12 | |
| Diluted EPS ($) | 3.24 | 4.10 | 4.73 | 5.28 | 5.50 | 5.70 | 6.01 | 7.25 | 10.72 | 12.19 | 14.33 | 16.03 | 18.08 | 21.18 | 23.86 | 15.51 | 13.23 | 15.55 | |
| Diluted shares (bn) | 1.179 | 1.131 | 1.087 | 1.046 | 1.023 | 0.986 | 0.967 | 0.968 | 0.985 | 0.983 | 0.966 | 0.961 | 0.956 | 0.950 | 0.938 | 0.929 | 0.911 | — |
USD billions · SEC XBRL
UnitedHealth Group Incorporated — questions
- What is UnitedHealth Group Incorporated's revenue?
- $450.1B over the twelve months to 2026-06-30, up 6.5% year on year, from its 10-Q and 10-K filings.
- What is UnitedHealth Group Incorporated's net income?
- $14.1B over the twelve months to 2026-06-30.
- What is UnitedHealth Group Incorporated's free cash flow?
- $23.6B over the twelve months to 2026-06-30.
- What are UnitedHealth Group Incorporated's diluted earnings per share?
- $15.55 over the twelve months to 2026-06-30.
Every figure on this page comes from UnitedHealth Group Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.